SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Dicerna Pharmaceuticals, Inc. (DRNA)

Add DRNA Price Alert      Hide Sticky   Hide Intro
Search This Board:
Last Post: 9/30/2016 10:48:32 AM - Followers: 3 - Board type: Free - Posts Today: 0
Dicerna Pharmaceuticals, Inc.
Building 1
Suite 120
Watertown, MA 02472
United States
Phone: 617-621-8097

Dicerna Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery and development of treatments for liver diseases and cancers based on a proprietary RNA interference technology platform in the United States and internationally. The company’s development programs include DCR-PH1 for the treatment of primary hyperoxaluria 1 (PH1) through targeting the liver metabolic enzyme glycolate oxidase; and other rare inherited diseases involving disease target genes expressed in the liver, including hemophilia, porphyria, hypercholesterolemia, hemoglobinopathies, alpha-1-antitrypsin deficiency hepatocyte, inclusions, and others. It is also developing DCR-M1711 for the treatment of various cancers through targeting the MYC oncogene, a gene that causes or promotes cancer when abnormally expressed or activated, as well as a product candidate targeting the oncogene KRAS; and a second product candidate targeting an oncogene. The company has a research collaboration and license agreement with Kyowa Hakko Kirin Co., Ltd. for the research, development, and commercialization of drug delivery platforms and DsiRNA molecules for therapeutic targets, primarily in oncology; and a license agreement with City of Hope, an academic research and medical center, to manufacture, use, offer for sale, sell, and import products related to DsiRNA for the prevention and treatment of various diseases in humans. Dicerna Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Watertown, Massachusetts.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
DRNA News: Securities Registration Statement (simplified Form) (s-3) 10/13/2016 08:48:30 AM
DRNA News: Current Report Filing (8-k) 10/13/2016 08:36:55 AM
DRNA News: Biotechs with Key Corporate Developments 10/03/2016 09:00:00 AM
DRNA News: Dicerna Prioritizes Resources to Advance GalXC™ Product Candidates 09/26/2016 07:30:00 AM
DRNA News: Dicerna to Present at September Investor Conferences 09/06/2016 04:05:00 PM
#3   Possible breakout INTL 09/30/16 10:48:32 AM
#2   * * $DRNA Video Chart 09-29-16 * * ClayTrader 09/29/16 05:04:18 PM
#1   $DRNA DD Notes ~ stocktrademan 12/19/14 10:24:16 AM